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                            INTRODUCTION
Securing   the   airway   by   means   of   endotracheal   intubation   is  the    sine 
qua  non  of  our  modern  day  general  anaesthetic  practice.  The  advantage   of 
doing  so   have   been   emphasized,   elucidated   and   extolled   over  these  years.
But,  endotracheal intubation is  not  entirely  harmless  and  we  come  across 
many  number  of  complications  associated  with  it  ranging  from  relatively  minor  to 
the seriously  grave and  potentially life threatening ones  which  would  occur  in 
susceptible  patients.
Though   these   complications   could  be  traced  down  to  any  of  the  many 
procedures that  are  part  and parcel  of  the sequence of  induction of  anaesthesia  and 
intubation,  laryngoscopy  and endotracheal intubation  are  the most  powerful  noxious 
stimuli   which  require  a  deeper level  of  anaesthesia  than  that   is   needed  for 
surgical  incision1.
In   anaesthesia,  circulatory  stimulation  during  tracheal  intubation  results  from 
both direct laryngoscopy and placement of the tube in the trachea.  These stimuli often 
evoke sympathoadrenal responses characterized by   alterations   in   systemic  arterial 
pressure,  heart rate , cardiac rhythm,  ST segment changes, pulmonary oedema  and 
rupture   of   cerebral   aneurysm2.   In  anaesthetized  humans,  the  usual  circulatory 
responses  to  laryngeal   and   tracheal  stimulation  are  tachycardia  and  systolic 
hypertension.  When planning the anaesthetic induction, these effects must be  blunted 
to whatever degree is possible, especially, if the patient is in a high  risk  population  like 
patients  with  uncontrolled   hypertension,  coronary  artery  disease,  asthma,  elevated 
intracranial pressure, cerebral aneurysm etc1.
          Different techniques have been used to attenuate this hemodynamic response to 
laryngoscopy  and intubation.   These  include  topical  anaesthesia  of  the  oropharynx3, 
intravenous lignocaine3, intravenous fentanyl4,5, alfentanil5, sodium nitroprusside6, beta-
adrenergic  blocking  drugs7,8,9,  alpha-2-adrenergic  agonists10,  alpha  and  beta-blockers, 
calcium channel blockers etc.
Prof.  Ward  and  king  (1960)  in  their  study  documented  myocardial  ischemic 
changes  due  to  reflex   sympathoadrenal   response  with  a  mean  increase in systemic 
pressure of  about +40 mm of Hg even in normotensives   following  laryngoscopy  and 
endotracheal  intubation. Prys-Roberts et al (1971)2 showed that this response is even 
more exaggerated in hypertensive individuals.
Considering  all  these  factors,  attenuation  of  hemodynamic  response  to 
laryngoscopy and endotracheal intubation will be a laudable objective and is definitely 
indicated.
 In our study that was carried out in the department of Anaesthesiology, Thanjavur 
Medical College and Hospital,   we compared the efficacy of oral clonidine and oral 
atenolol with a control group to determine  how effective they are in attenuating the 
cardiovascular stress response to laryngoscopy and tracheal intubation.
 
                                 
         
                        AIM OF THE STUDY
The    present   study   was   done   to   compare   the  effectiveness   of         oral  
clonidine   and   oral   atenolol   in   attenuating   the   hemodynamic   response   to 
laryngoscopy  and  endotracheal   intubation. 
    
      PHYSIOLOGIC   AND   PATHOPHYSIOLOGIC 
RESPONSES TO   DIRECT LARYNGOSCOPY 
                        AND INTUBATION
Direct   laryngoscopy   and   tracheal intubation  are  both  potent stimuli   that   may 
instigate  an  intense  autonomic  response11.  Tracheal intubation  alters  respiratory  and 
cardiovascular  physiology  by reflex response  and by  the  physical  presence  of 
endotracheal  tube. Although   these  circulatory responses  are transient  and  of little 
consequence  in  patients  with   normal circulatory system,   it  could  have  an  adverse 
effect in patients with  poorly  controlled  hypertension,  critical  myocardial  ischemia 
or those   with   raised  intracranial  pressure1.
CARDIOVASCULAR RESPONSE:
This transient, variable  and  unpredictable  response  is  mediated  by  both sympathetic 
and  parasympathetic nervous system. Bradycardia seen in infants  and  small  children 
during  direct laryngoscopy and intubation is the  autonomic equivalent of laryngospasm 
response  in  adults. This reflex is  mediated  by  an  increase  in  the  vagal tone at  the 
sinoatrial node  and is  virtually  a  monosynaptic  response  to  noxious  stimuli  in  the 
airway.
The  more  common  response   to  tracheal intubation is hypertension and tachycardia.  This   pressor 
response   is   mediated   by    sympathetic  efferent  via   the   cardio  accelerator  nerves   and   the 
sympathetic chain ganglia12.  The polysynaptic  nature  of  pathways  from the  IX (Glossopharyngeal 
N) and X (vagus Nerve)  nerve afferents  to the  sympathetic nervous system   via the   brainstem  and 
spinal cord  results   in  a  diffuse autonomic response  which   includes  widespread   release  of  nor-
epinephrine  from  the adrenergic terminals   and  from  the  adrenal  medulla. One  other  reason for 
the  hypertensive  response  is  due  to  activation  of                         renin – angiotensin system   with  
the  release  of   renin  from  the                         renal  juxta-glomerular  apparatus,  which   is  an  end  
organ   innervated    by adrenergic  nerve  terminals.
BRONCHOMOTOR  RESPONSE :
 Mechanical stimulation of the epipharynx, laryngopharynx and tracheobronchial tree 
causes 12
i. Glottic closure reflex (laryngospasm)  which is  a brisk motor response,
ii. Reduction in dead space,
iii. Increase in airway and total lung resistance,
iv. Bronchospasm which  is  a   reflex response to intubation   and 
 v.      Reduction in cough efficiency.
METHODS  TO  ATTENUATE  CIRCULATORY 
RESPONSES  TO  LARYNGOSCOPY  AND 
                                                INTUBATION
1) Deepening of general anesthesia:
 Volatile  anaesthestic  agents can  be  used  to  deepen   the  plane  of  anaesthesia. 
MAC intubation  is  30%  higher  than  MAC  incision.   
         
2) Shortening  the duration  of  laryngoscopy  to  less than  15 seconds  
because  longer  the   duration  more  is  the  pressor  response3.
3) Short acting Opioids.
  Fentanyl 4,5– 2-5 microgram  per kg, 3 minutes prior to induction. 
               
 Alfentanil5 – 15 –30 microgram  per kg  just  before  induction.
               
 Sufentanil – 10-30 microgram  per kg, 3 minutes prior to induction. 
               
 Remifentanil13- 1-2 microgram  per kg  just  before  induction.
               
 4) Lignocaine.
Intravenous  lignocaine14  1.5 milligram per  kilogram    administered   90 seconds  prior 
to   induction   of   anaesthesia   or   topical   administration   of   Laryngotracheal 
lignocaine3  2 milligram per  kilogram  immediately  before  placing  the  tracheal  tube 
can  be  used.
5)  Vasoactive Substances.
a) Nitroglycerin    -  2  microgram per kilogram 15 seconds  prior  to  laryngoscopy,  
b)  Sodium  nitro  prusside  6    -  1-2  microgram  per  kilogram  15  seconds   prior   to 
laryngoscopy  briefly  decreases  vascular  tone but   the  exact  dose  required for  each 
patient is  difficult to determine.
6) Adrenergic Blockers.
a)  Alpha and beta blockers:
               
Labetolol  –  100  to  250  µg/kg   given  intravenously   atleast   3  minutes  prior 
to  intubation.
b)Beta blockers:
Esmolol7,9 – 1 to 2 milligram  per   kilogram given  intravenously  about  15  seconds 
prior to  induction of  anaesthesia.
Propranolol8 - 0.5 to 1 milligram  given  intravenously  about  4  minutes    to induction 
of  anaesthesia.
Metoprolol9-  4 milligram  as an  intravenous  bolus  about  3 minutes  prior to  induction 
of  anaesthesia.
Mechanism  of   action   of   beta  blockers  is   by    their   negative   inotropic   and 
chronotropic  action  on  the  heart   which  prevents  the increase in heart rate  and 
blood  pressure  increase  in  response  to stress or  noxious stimuli15. Cardio selective 
beta  blockers  are  the  most  useful.
 c) Calcium channel blockers :  
Nifedipine,  verapamil,  diltiazem    can  be  used.
Verapamil   is effective among   the  calcium- channel blockers to blunt the hypertension 
and tachycardia seen with intubation.
d) ACE inhibitors   : 
Captopril  or  enalapril  can  be  given  45  minutes  prior  to  induction.
e) Alpha-2 agonists:     
Clonidine10  4 to 5 microgram per kilogram  orally  60-120 minutes  prior  to  intubation. 
Dexmedetomidine   and    mivazerol     are  also  useful.           
Mechanism of action  of  alpha-2  agonists  is  by   decreasing central sympathetic 
outflow,   increasing  the  parasympathetic  tone   and   by   decreasing  circulating 
noradrenaline concentrations15. 
PARMACOLOGY OF CLONIDINE
Clonidine   is   a   prototype,   partially   selective   alpha-2   adrenoreceptor   agonist 
(alpha-2: alpha-1 = 220:1).  It  is  a  centrally  acting  imidazole compound.  It was 
synthesized in the early  1960s  as  a vasoconstricting nasal decongestant15.
STRUCTURAL FORMULA:
MOLECULAR FORMULA:
                 (2-(2,6- dicholorophenylamino)-2-imidazoline) 
PHYSICAL PROPERTY:
                  Molecular weight – 266.56
PREPARATIONS:
1. Tablets – 0.1mg, 0.15mg, 0.2mg, 0.3mg
2. Injection (Parenteral) – 0.15mg/ml ampoule (1ml)
3. Injection (Preservative Free): For epidural and spinal injection  (0.1mg/ 1ml)
4. Transdermal therapeutic patch releases
0.1mg/ 24 hours
0.2mg / 24 hours
0.3mg / 24 hours
ROUTES OF ADMINISTRATION:
     It  can  be  given  as  oral  tablets, intravenous  injection, Subarachnoid or epidural 
injection,  as  an   additive   for   regional  nerve  blocks   and    intravenous  regional 
anesthesia.
PHARMACOKINETICS:
                  Oral Clonidine is well absorbed with a bioavailability of nearly 100%.   The 
onset  of action starts from 30 to 60 minutes.  The peak effect  is  between 60 to 120 
minutes and its action lasts for up to 8 hours15.   Clonidine has a low to moderate protein 
binding capacity (20 – 40%). It has an elimination half-life of about 6 to 24 hours with a 
mean of about 12 hours. The  elimination half life is increased up to 40 hours in patients 
with renal  dysfunction.
      
                 There is good correlation between the plasma concentration of   clonidine  and 
its  pharmacological  effects.
METABOLIS  M  AND   ELIMINATION  :  
                  Nearly 50% of clonidine is eliminated unchanged in the urine and remaining 
drug undergoes hepatic biotransformation.  Biliary and faecal   excretion is responsible 
for  20% of drug elimination.
PHARMACODYNAMICS:
Clonidine acts on various systems in the body.
CARDIOVASCULAR  SYSTEM:   
Clonidine has got both  central action and peripheral action.          
Central action: - 
Activation   of  central  alpha-2  adrenergic  receptors  in  medullary  vasomotor  center 
inhibits  the  release  of  nor  epinephrine  from  the  adrenergic  neurons   and  reduces 
sympathetic  outflow from the   CNS.  Further,  there  is   reduced  discharge  from the 
Plasma  Concentration  of  clonidine 
(mg/ml) 
          Pharmacological effects 
                 About 1                Salivary flow reduced
                > 1.5 – 2                 Sedation to Sleep
                 Up to 1.5 - 2                   Hypotension
                   >2                 Vasoconstriction to 
                      Hypertension
postganglionic fibres of   cardiac nerves and an  increase  in parasympathetic tone15.
 This results  in  decrease  in  blood pressure,  heart rate,   cardiac output and peripheral 
vascular resistance.
Nucleus tractus solitarius, the site that modulates the autonomic control including vagal 
activity is an important central site for the action of Clonidine15.
Other proposed sites of action are locus coeruleus, dorsal motor nucleus of vagus and 
nucleus  reticularis lateralis.
Reduction in sympathetic tone is accompanied by lowering of plasma renin activity, 
decrease in renal vascular resistance and maintenance of renal blood flow even when the 
blood pressure is lowered.  Vasopressor centers of the brainstem retain their sensitivity 
to baroreceptor  control  and hence postural  hypotension is  considerably less  than the 
effects of drugs that act on the autonomic ganglia and peripheral adrenergic neurons.  
The absence of  a fall  in blood pressure when Clonidine is  given to tetraplegic  with 
complete spinal cord transection above the level of sympathetic outflow also suggests a 
central site of hypotensive action15.
Peripheral  action:
These   are  mediated  by   inhibition  of  norepinephrine  release  from  the  peripheral 
prejunctional nerve endings and by decreasing plasma concentration of norepinephrine. 
CORONARY CIRCULATION:
The  direct  effect  of  alpha-2  agonists  on  coronary  vasculature  is  vasoconstriction. 
However, this is offset by the generalized reduction in sympathetic outflow.
CENTRAL NERVOUS SYSTEM
Clonidine   has   got   a   sedative   and   anxiolytic   action16.  The  sedative  effect  of 
clonidine may be due to decreased tonic activity of the  locus coeruleus which modulates 
the stimuli arriving in  the central nervous system15.  It  has  got  a  potent  spinal  and 
supraspinal  analgesic  action.  Clonidine  has  got  opioid  sparing  effect and  it  reduces 
the   anaesthetic   requirements.  It  reduces   the   MAC   value   of   halothane  and 
isoflurane17.  It  suppresses physiological and psychological symptoms after  withdrawal 
of  opioid, alcohol, benzodiazepines, barbiturate, nicotine etc. in addicted patients
RESPIRATORY SYSTEM:
Clonidine  has  minimal  bronchodilating  and  respiratory  depressant  activity.
ENDOCRINE SYSTEM:
Clonidine   suppresses insulin secretion, decreases utilization of glucose by tissues and 
may  cause  hyperglycemia. It inhibits  the  secretion  of renin.
GASTROINTESTINAL SYSTEM:
Clonidine decreases salivary flow. It  prevents intestinal ion and water secretion in the 
large bowel.
USES:
i)  Preanaesthetic  medication:
Dose:   3-5microgram  per   kilogram orally  60 – 120 minutes  prior  to  induction of 
anaesthesia. When given as a premedicant,  clonidine provides sedation16 , anxiolysis16, 
antisialogogue  effect,   decreases  the  dose  of  induction  agent,  attenuates  the 
hemodynamic response to laryngoscopy and intubation10,16,  decreases the intraoperative 
lability  of     blood pressure and heart rate,  decreases MAC of inhalation agents17,18, 
provides   analgesia,   reduces  narcotic  requirements19 and  decreases   postanaesthetic 
shivering20.
ii) Spinal and epidural analgesia:
Preservative free clonidine injected epidurally (2 to 10 microgram per kilogram diluted) 
or  into  the  subacachnoid  space  (0.3  –  3  microgram  per  kilogram)  produces  dose 
dependant analgesia. It  acts on the  substantia gelatinosa   of the spinal cord,   inhibits 
substance P release and nociceptive neuron firing produced by noxious stimuli.
iii) Prolonging the effect of regional anesthesia: 
oral clonidine prolongs the duration of tetracaine spinal anaesthesia  and  when added to 
local anaesthetic solution prolongs brachial plexus block and  caudal analgesia.
iv) Treatment for post anesthetic shivering:
Inj. Clonidine 3 microgram per kilogram administered intravenously  inhibits or stops 
shivering  mechanism is by inhibition of central  thermoregulatory control.
v) Attenuation of hemodynamic effects of ketamine:
Oral Clonidine attenuates the heart rate and blood pressure increase that usually follows 
ketamine administration21.
vi) Diagnosis of phaeochromocytoma: 
Lack   of   suppression  of   plasma   norepinephrine   to  less than
500  picogram  /  ml,  3  hours  after  a  oral  dose  of  0.3mg  Clonidine  suggests 
phaeochromocytoma15.
vii) Treatment of diabetic diarrhoea.
viii) Treatment of hypertension : 
It is not  used  as  a  first line  antihypertensive. 
ix) Induced hypotension:
Clonidine is a  useful adjunct in inducing deliberate Hypotension.
ADVERSE EFFECTS :-
Clonidine can  cause bradycardia and  hypotension.  Sedation  and   dry mouth  occur in 
50%  of cases.  It  may  cause  dryness of nose and eyes. It  may  sometimes  cause 
parotid gland swelling and pain. Less common  side  effects like  sleep disturbances with 
vivid dreams or nightmares,  restlessness, depression  and  impotence may  occur  in 
some  patients.
CLONIDINE  WITHDRAWAL  PHENOMENA :-
Sudden discontinuation of  Clonidine  results in headache, apprehension , tremors, abdominal pain, 
sweating , tachycardia and hypertension.  It  occurs usually 18-24 hours after stopping the drug. It 
occurs  because  of   increased sympathetic discharge  resulting  in   increased  plasma and urinary 
catecholamine concentration.  It is dose related , occurring rarely in patients taking  a daily dose of 
Clonidine  0.3mg or less and more frequently and  severely upon discontinuation of higher doses15.
DRUG INTERACTION:-
1) Diuretics potentiate hypotension  caused  by  clonidine.
2) Tricyclic  antidepressants  inhibit  the  antihypertensive  effect  of  Clonidine   by  an 
unknown   mechanism.
OVERDOSE :-
It  results  in  depression of sensorium,  transient hypertension followed  by hypotension 
and  bradycardia.  It   may  cause  respiratory depression  and  miosis  which  resembles 
the  effects of  opioid  overdosage. 
In  case  of  overdosage,  ventilatory support and  circulatory support  with crystalloids, 
colloids, inotropic agents  and  atropine are  needed.
CONTRA-INDICATIONS:-
Clonidine  is  contraindicated   in  patients  with  sinus node disease and  atrioventricular 
node dysfunction. It  is to  be  avoided  in  patients on diuretics  having  hemodynamic 
instability  and in pregnant   females.  It   should  never  be  prescribed  to  a   non-
compliant patient  who do not follow the instructions.
      
                        PHARMACOLOGY OF ATENOLOL
Atenolol is a Beta (1)-selective (Cardio-selective)  adreno-receptor antagonist.
Chemical Name:
              (RS)-4-(2-hyproxy 3-isopropylamino propoxy) phenylacetamide 
Structure: 
                  (C14 H22 N2 O3 ) 
Physical properties: 
It  is  a  white,  odourless  powder.  It  has  no  intrinsic  sympathomimetic  activity  or 
membrane – stabilizing activity15.
 
Melting point 152-155 0c
Dissociation constant 9.6 @ 24 0c
Partition co-efficient  Log Kp* 0.23
            
    (* Log Kp – octanol: water partition co-efficient)
Absorption, fate  and  excretion :
It is incompletely absorbed with only 50% oral bioavailability.                                    But 
most of the absorbed drug reaches the systemic circulation (hydrophilicity). There   is 
only  little  inter-individual variation  in the plasma concentration of atenolol. 
It  crosses  the  Blood - Brain Barrier only to a limited extent and its peak effect  is 
between 60- 120 minutes15.  Atenolol is excreted largely unchanged in urine and the 
drug accumulates in patients with                     renal failure.  It has an elimination half-
life of 5-8 hours. The dosage should be reduced in patients with creatinine clearance   of 
less than  
35milliliters per minute.                                      
PHARMOCOLOGICAL ACTIONS:   
Effects of Beta-Blockade: -
Atenolol acts as a competitive inhibitor at beta-1 receptors, which are predominant in 
the heart. It has no marked effect on the normal  heart in subjects at rest. But  in   the 
presence  of  increased  sympathetic tone  as with  stress  or  exercise, the Beta-
Blockade in the heart prevents a rise in  heart rate,  cardiac output  and   stroke work.
It results in reduction in myocardial contractility,  suppression of automaticity and 
slowing down of atrio- ventricular conduction. The cardiac response to exercise and 
other  stressful  conditions  in  which  sympathetic  tone  is  increased  is  attenuated. 
Further, it decreases myocardial oxygen requirement and improves exercise tolerance 
in patients with angina.
Activity as an  antihypertensive agent:-
Atenolol does not cause a reduction in blood pressure in patients with normal blood 
pressure15.  It  lowers  blood  pressure  only  in  patients  with  Hypertension.  The 
mechanism  responsible  for  this  important  clinical  effect  is  not  well  understood 
despite its wide spread use.
The  release  of  renin  from  the  juxta-glomerular  apparatus  is  stimulated  by  the 
sympathetic nervous system and atenolol blocks this effect. Long-term administration of 
atenolol  to  hypertensive  patients  ultimately  leads  to  a  fall    in  peripheral  vascular 
resistance.  Though  it has been hypothesized that the central actions of atenolol may 
also contribute to the antihypertensive effect, there is only little evidence available.
Pulmonary system:
Atenolol is less likely to increase airway resistance in patients with asthma. But, it has to 
be used with caution in patients with bronchospastic disease. 
Uses:
1)Anti-hypertensive :
Atenolol   is used  to  reduce  increased   blood pressure.  Initial dose is 50 mg/day once 
daily.   If the patient   does not   respond   after 3-4 weeks  of   therapy, the  dose has to 
be   increased to l00 mg/ day once daily.
 2)Anti-anginal: 
Atenolol relieves angina and improves exercise   tolerance.
3) Anti- arrhythmic:
  Atenolol is a class II anti-arrhythmic agent that helps to control the ventricular response 
rate  in   chronic  Atrial  fibrillation,  Supraventricular  tachycardia  and  in  symptomatic 
premature ventricular complexes. 
4) Atenolol reduces mortality and improves early survival in patients with myocardial 
infarction.
5) In hyperthyroidism: 
Atenolol is effective in controlling sympathetic over activity. It  controls the anxiety, 
tremor and tachycardia seen in these patients.
6) Tremors: 
Though propranolol is the best choice, atenolol can be used to control essential tremors.
7) Anxiety disorders:  
Atenolol  reduces  anxiety  in  patients  with  acute  stress  reactions,  generalized  anxiety 
disorders and panic disorder.
8) Alcohol withdrawal: 
Atenolol  is  used as an adjunct to standard alcohol withdrawal treatments.
Adverse effects: 
The most frequent and serious side effect of Atenolol is because of its beta blockade.
1) Cardio vascular system  :   Atenolol  may cause bradycardia, hypotension,  heart 
block and  congestive cardiac failure. Abrupt withdrawal of atenolol  in chronically 
treated patients  may precipitate angina and sudden death.
2) Bronchospasm:   It can occur with Atenolol in susceptible patients.   
 
3)  Central nervous system:    Atenolol may cause  fatigue, depression, confusion, 
insomnia and nightmares.
4) Gastrointestinal  effects:  Atenolol  can  cause  nausea,  vomiting,  diarrhoea, 
constipation and abdominal cramps.
   5) Raynaud’s phenomenon:  Atenolol can worsen symptoms of peripheral vascular 
disease and may cause cold extremities
PRECAUTIONS: 
1.Bronchospastic disorder: 
  Though  cardio  selective,  atenolol  should  not  be  given  to  a  patient  with 
bronchospasm. 
2. Diabetes Mellitus:
Atenolol  blunts  the  recognition  of  hypoglycemia  by  patients  with  diabetes 
mellitus and is known as hypoglycemia unawareness.
3. Patients on long term treatment with atenolol:
Abrupt withdrawal of atenolol results in angina, myocardial infarction, ventricular 
arrhythmias  and  sudden  death.  Medication  has  to  be  discontinued  gradually  over  a 
period of 1-2 weeks.
OVERDOSAGE:  
Atenolol  overdosage  may  cause  hypotension,  bradycardia,  prolonged  PR  interval, 
widened QRS complex, seizures and depression.
DRUG INTERACTION:
i. Atenolol  and  calcium  channel  blockers  have  an  additive  effect  on  cardiac 
conduction system.
ii. Indomethacin  and  other  non  steroidal  anti-inflammatory  drugs  can  antagonize 
anti-hypertensive effect of atenolol.
            
             MATERIALS AND  METHODS
Following local ethics committee approval, 75 ASA grade I or II patients of either 
sex aged from 20 to 60 years scheduled for various elective surgeries under general 
anaesthesia were included in the study. All of them required orotracheal intubation as 
part of their anaesthetic management and gave written informed consent to participate in 
the study.
Patients  with  cardiovascular  disease,  bronchospastic  disease,  cerebrovascular 
disease, peripheral vascular disease, hepatic and renal impairment,  Diabetes mellitus, 
morbid obesity, anticipated  difficult airway and those taking vasoactive drugs that are 
known to affect heart rate, blood pressure or hormonal stress responses were excluded 
from the study.
All  patients  were  assessed  preoperatively  by  history,  physical  examination, 
routine laboratory tests, chest X-ray and electrocardiogram.  A preoperative  visit  was 
made  to allay  the  anxiety  and  to  develop  a  good  rapport. 
On     the   day  of   surgery ,   patients were  examined   in   the waiting room  and 
a base line   pulse rate , blood pressure  (systolic, diastolic and mean arterial pressure ) 
and   respiratory  rate  were  recorded.   These  values  were  noted  down  as the 
preoperative value   (PO). Then the   patients  were   randomly  assigned  into   three 
groups  of  25  patients  each. Group I:  control  group  patients  received  T.Diazepam 
0.1mg/kg  (rounded off  to the nearest  5mg).   Group II:  clonidine   group  patients 
received  T. Clonidine (CATAPRES)   5 microgram / kg,  rounded   off   to  the  nearest 
50 microgram (maximum 0.3 mg)  in  addition  to  T.Diazepam 0.1mg/kg   rounded  off 
to  nearest   5 mg. Group III:  Atenolol group patients  received   T.Atenolol  50 mg 
(TENORMIN)   in  addition  to              T. Diazepam 0.1mg/ kg   rounded  off   to 
nearest   5 mg.  All the drugs were  given  with sips  of  water  about  2  hours  prior  to 
induction of  anaesthesia . No  anticholinergic  drug  was  given  either  before  or  at the 
time  of  induction  of  anaesthesia. 
In  the  waiting room, just before shifting the patients to operation  theatre   (2 
hours  after the study drug),  an  assessment  of  sedation  and respiratory rate was done.
The degree of sedation was graded as follows
 Sedation scoring22: 
0      -  patient   awake  and   talkative 
1      -   patient   awake but   uncommunicative. 
2      -   patient   drowsy,  quiet  and easily arousable.
3      -   patient  asleep.
  On  arrival in the operating room a 18 gauge intravenous cannula was placed and 
crystalloid  was  started . Patients were monitored with a               non-invasive monitor 
throughout the study period.   Monitored    parameters     include   heart rate,   blood 
pressure   ( systolic, diastolic and  mean arterial pressure ) , oxygen saturation    and 
electrocardiogram. 
After  a  stabilization  period  of  3  minutes  a  baseline  heart  rate,  blood pressure 
(systolic, diastolic and  mean arterial pressure)  were   recorded. These  values  were 
noted down as  preinduction  values  (PI). All the patients were   preoxygenated  with 
100%  oxygen  for  3 minutes. Patients were  induced  with Inj. Thiopentone sodium 
2.5% - 5 mg / kg intravenously followed  by  Inj.  Succinylcholine 1.5 mg/ kg  body 
weight. A digital stopwatch was used to time the events.
Heart rate and  blood pressure ( systolic, diastolic and mean arterial pressure ) 
were   recorded  during  laryngoscopy and endotracheal intubation  (LI)  and   thereafter 
at  one, three  and  five  minutes  after  intubation  ( I-1,  I-3   and  I-5    respectively).
All patients were intubated with appropriate size cuffed, portex endotracheal tube.
Any  patients  who  strained  or  took  more  than  15  seconds  of  laryngoscopy  or 
required  a  second attempt of laryngoscopy and intubation were excluded from the 
study.
 All  patients were ventilated using O2 : N2O = 40% :60%,                             inj. 
Vecuronium 0.08 mg per  kg  without any addition of narcotic or volatile anaesthetic 
agent. No surgical  stimulation  was  allowed  for  five  minutes  after  intubation. 
Intraoperatively,  patients  were  observed  for  side  effects  like  hypotension, 
bradycardia, hypertension, tachycardia and arrhythmias.
Inj.  Pentazocine 0.6 mg/kg   was  given   intravenously after  the observation 
period  (5  minutes  after  intubation).  After  completion  of  surgery,  neuromuscular 
blockade was reversed   with   Inj. Neostigmine   0.04  mg/kg  and  Inj.  Atropine  0.02 
mg/kg   intravenously. Patients were extubated after thorough suctioning  and shifted to 
postoperative ward.  Any delay in recovery was noted.
          Patients  were  observed  for  complications  like  hypotension,  bradycardia, 
hypertension, tachycardia, vomiting, shivering in the postoperative ward.  They were 
observed every 1-hour up to 12 hours and thereafter every  2 hours  up to 24 hours.
          Results  were  systematically  analysed  by  ‘t’-test  to  find  out  the  significance 
between  the  groups   and  in   the  groups  at  different  periods  of   study  from  the 
preoperative  basal   value.    A  p-value  of   less  than   0.05  was  considered  as 
statistically  significant.
  OBSERVATION  AND  RESULTS
The  mean  age  and  mean  weight  of  the  patients  in  all  the  three groups  were 
comparable.  The  number  of  males (9)  and  females (16)  were  equal  in  all  the 
three  groups.
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TABLE  II:  SEDATION  SCORING  IN  DIFFERENT  GROUPS 
GROUPS
  
               S E D A T I O N        S C O R E 
         0          1           2
 
          3
CONTROL     15 (60%)      8 (32%)       1 (4%)       1 (4%)
CLONIDINE       2 (8%)      3 (12%)      10 (40%)     10 (40%)
ATENOLOL    16 (64%)       8 (32%)         1 (4%)        0 (0%)
Clonidine    provided  better  sedation  (  80% of  patients  in   sedation  score  2-3 ) 
when  compared  to  control  and  atenolol  group  ( 60%  of  patients  remaining  awake) 
. There   was   no  significant  difference  in  sedation  between  control  and  Clonidine 
group.
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TABLE  III:  CHANGES  IN   HEART  RATE (MEAN  ±  STANDARD 
DEVIATION  BEATS  PER  MINUTE )  IN  ALL THE  THREE  GROUPS 
COMPARED  WITH  THEIR  RESPECTIVE  PREOPERATIVE  VALUES 
AT  DIFFERENT  TIME  INTERVALS.
TABLE   III:
HEART RATE  (MEAN ± S.D)  IN  BEATS PER MINUTE 
       TIM
E
               GROUPS
CONTROL CLONIDINE ATENOLOL
PO 80.88 ± 6.98 81.84 ± 5.68 80.8 ± 5.09
PI 91.64 ± 7.17 74.76 ± 3.503 75.44 ± 4.27
LI 112.8 ± 7.08 87.28 ± 3.13 87.2 ± 4.66
I-1 115.24 ± 6.35 84.68 ± 3.997 89.96 ± 3.96
I-3 103.68 ± 4.375 73.92 ± 3.818 84.08 ± 4.28 
I-5 96.56 ± 4.375 72.28 ± 2.89 79.36 ± 4.03
In  the  preoperative  period,  before  giving  the  premedication  the  mean  heart rate 
in  all  the  three  groups    were  comparable as in 
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TABLE  III.   Before     induction   of   anaesthesia,  90 – 120   minutes  after 
premedication, the   heart rate( mean ±  S.D)  significantly   decreased   from  the 
preoperative  value  in  clonidine  and  atenolol  group  (p<0.05)  whereas   it  was 
significantly  increased  in  the  control   group (p<0.05) (TABLE  III).  During  this 
period,   the  decrease  in  heart  rate   from  81.84 ±5.68   and   80.8±5.09   to 
74.76±3.503   and   75.44±4.27  respectively  in the  clonidine  and  atenolol    group 
was  significant  when  compared  to  the  increase  in  heart rate  from  80.88 ±6.98 
to  91.64±7.17  in   control   group (p  <  0.05)   but   there   was   no   significant 
difference  between  clonidine  and  atenolol  group  (p >0.05).
 During  direct  laryngoscopy  and  endotracheal  intubation,  there  was  significant 
increase  in  heart rate (mean ± S.D )  from  their  respective  preoperative  values  in 
all  the  three  groups ( p < 0.05).  However,  the   increase  in  heart rate (mean ± S.D 
)  was  significantly   lower  in  the  clonidine  and  atenolol  group when  compared 
to  the  control  group    (increased  by  30% in  control  group , by  6% in  clonidine 
group,           by  10% in  the  atenolol group, p<0.05)  but  there  was  no  significant 
difference    between   clonidine   and   atenolol   group (p>0.05).
The  heart  rate (mean  ±  S.D)  returned  to  preoperative  value  at  one  minute  after 
intubation  in  the  clonidine  group,  at  five  minutes  after  intubation  in  the 
atenolol  group  whereas  in  the  control  group  it  remained  significantly  higher  at 
five  minutes  after  intubation.
After  intubation,  during  the  observation  period  of   five  minutes , the  decrease 
in  heart  rate  in  atenolol  group  was  significantly  less than  the  Clonidine  group ( 
p <0.05)   but  was  significantly  more  than  the  control  group  ( p < 0.05).  
  
The  systolic  blood pressure  in  the  preoperative  period  was  comparable  in  all 
the  three  groups (TABLE IV).   During  the  preinduction  period,  2 hours  after 
premedication, the blood pressure  increased  significantly  in  the  control  group 
(p<0.05) but it  decreased  in  the  clonidine  group (p<0.05)  and  atenolol  group 
(p>0.05).
TABLE  IV:  CHANGES  IN  SYSTOLIC  BLOOD  PRESSURE  (MEAN ± 
STANDARD DEVIATION   mm  of  Hg)   IN  ALL THE  THREE  GROUPS 
COMPARED  WITH  THEIR  RESPECTIVE  PREOPERATIVE  VALUES 
AT  DIFFERENT  TIME  INTERVALS.
TABLE   IV:
SYSTOLIC  BLOOD  PRESSURE  (MEAN ± S.D)  IN  mm  of  Hg 
      TIME
                     G R O U P S
CONTROL CLONIDINE ATENOLOL
PO 113.04 ± 9.697 114.16 ± 7.636 113.36 ± 9.604
PI 118.08 ± 8.154 105.84 ± 4.47 110.08 ± 8.376
LI 150.44 ± 9.39 127.8 ± 5.902 127.68 ± 6.414
I-1 152 ± 9.63 131.28 ± 5.35 131.96 ± 5.93
I-3 143.68± 8.86 110.72 ± 6.23 116.52 ± 7.611
I-5 127.04 ± 6.88 105.8 ± 5.21 112 ± 7.49
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During  laryngoscopy, endotracheal  intubation and  at  one  minute  after  intubation, 
the  systolic  blood  pressure  increased in all  the three  groups  but  the  increase  was 
significantly  less in  the  clonidine  group  and  atenolol  group when  compared  with 
the  control  group (increased  by  26% in control group  vs. 13% in  clonidine group 
and  14% in  atenolol  group,  p<0.05) .
The raised systolic  blood pressure  returned  to  preoperative  level  at  three minutes 
after  intubation  in  the  clonidine  group, at  five minutes  after  intubation  in  the 
atenolol  group  whereas  in  the  control   group, it  did not  return  to the  preoperative 
level  at  five  minutes  after  intubation.
During  the  preoperative  period,  the  diastolic  blood pressure was  comparable  in  all 
the  three  groups  (  TABLE V).  During  the  preinduction  period,  the  diastolic 
pressure  decreased  from  the  preoperative  values in  clonidine group  (p<0.05) and 
atenolol group (p>0.05)  whereas  the  diastolic  pressure  increased  in  the control 
group (p>0.05).
TABLE  V:  CHANGES  IN DIASTOLIC  BLOOD  PRESSURE  (MEAN ± 
STANDARD DEVIATION   mm  of  Hg)   IN  ALL THE  THREE  GROUPS 
COMPARED  WITH  THEIR  RESPECTIVE  PREOPERATIVE  VALUES 
AT  DIFFERENT  TIME  INTERVALS.
TABLE   V:
DIASTOLIC  BLOOD  PRESSURE  (MEAN ± S.D)  IN  mm  of 
Hg 
       TI
ME
                           G R O U P S
CONTROL CLONIDINE ATENOLOL
PO 75.68 ± 5.186 76 ± 4.397 75.12 ± 4.4
PI 77.2 ± 2.944 72.08 ± 3.26 73.28 ± 4.505
LI 97.48 ± 4.805 84.76 ± 2.21 83.84 ± 4.26
I-1 97.84 ± 3.77 88.28 ± 2.303 87.44 ± 4.17
I-3 93.32 ± 4.12 77.16 ± 2.48 79.4 ± 3.89
I-5 83.4 ± 3.71 72.04 ± 3.129 77.44 ± 4.05
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During  laryngoscopy, endotracheal  intubation and  at  one  minute  after  intubation, 
the  diastolic  blood  pressure  increased in all  the three  groups  but  the  increase  was 
significantly  less in  the  clonidine  group  and  atenolol  group when  compared  with 
the  control  group (increased  by  23% in control group  vs. 14% in  clonidine group 
and  14% in  atenolol  group,  p<0.05) .
The raised distolic  blood pressure  returned  to  preoperative  level  at  three minutes 
after intubation  in  the  clonidine  group, at  five   minutes  after  intubation  in  the 
atenolol  group  whereas  in  the  control   group, it  did not  return  to the  preoperative 
level  at  five  minutes  after  intubation.
During  the  preoperative  period,  the  mean  arterial pressure was  comparable  in  all 
the  three  groups ( TABLE VI).
During  the  preinduction  period,  the mean  arterial pressure  decreased  from  the 
preoperative  values in  clonidine group  (p<0.05) and  atenolol group (p>0.05)  whereas 
the  mean  arterial pressure  increased  in  the control  group (p>0.05). During 
 laryngoscopy, endotracheal  intubation and  at  one  minute  after  intubation,  the 
mean arteial  pressure  increased in all  the three  groups  but  the  increase  in  clonidine 
group  and  atenolol  group  was  significantly  
TABLE  VI:  CHANGES  IN  MEAN ARTERIAL  PRESSURE  (MEAN ± 
STANDARD DEVIATION   mm  of  Hg)   IN  ALL THE  THREE  GROUPS 
COMPARED  WITH  THEIR  RESPECTIVE  PREOPERATIVE  VALUES 
AT  DIFFERENT  TIME  INTERVALS.
TABLE   VI:
MEAN  ARTERIAL  PRESSURE  (MEAN ± S.D)  IN  mm  of  Hg 
       TIME
               GROUPS
CONTROL CLONIDINE ATENOLOL
PO 88.04 ± 6.08 88.68 ± 4.12 88.16 ± 5.93
PI 90.84 ± 3.91 83.4 ± 2.94 85.52 ± 4.66
LI 115.12 ± 5.64 98.76 ± 2.934 98.32 ± 4.29
I-1 115.96 ± 4.93 102 ± 2.5 102.24 ± 4.26
I-3 110.28 ± 4.89 88.28 ± 3.23 91.76 ± 4.32
I-5 98 ± 3.67 83.24 ± 3.07 89.2 ± 4.5
CHANGES  IN  MEAN  ARTERIAL  PRESSURE
60
80
100
120
PO PI LI I-1 I-3 I-5
TIME  INTERVAL
M
EA
N 
AR
TE
RI
AL
 P
RE
SS
UR
E 
(m
m
 o
f H
g)
CONTROL CLONIDINE ATENOLOL
less  when compared  to  control  group (increased  by  24% in control group  vs. 13% in 
clonidine group  and  14% in    atenolol  group,  p<0.05) .
The raised mean arterial  pressure  returned  to  preoperative  level  at  three minutes 
after intubation  in  the  clonidine  group, at  five minutes  after  intubation  in  the 
atenolol  group  whereas  in  the  control   group, it  did not  return  to the  preoperative 
level  at  five  minutes  after  intubation (TABLE VI).
TABLE  VII   shows  changes   in  respiratory  rate   90  –120  minutes   after 
premedication.  After  premedication,  there  was  no  significant  change  in the 
respiratory  rate in  any  of  the  groups (p>0.05).
TABLE VII:  CHANGES  IN  RESPIRATORY  RATES  IN  DIFFERENT 
GROUPS.
TABLE VII
         
 RESPIRATORY RATE (BREATHS PER MINUTE)
GROUP
BEFORE 
PREMEDICATION
120  MINUTES  AFTER 
PREMEDICATION
CONTROL       14.88 ± 1.364         15.12 ± 1.299
CLONIDINE       15.04 ± 1.24           15 ± 0.96
ATENOLOL      15.08 ± 1.19         15.12 ± 1.17
                      REVIEW OF LITERATURE
The hemodynamic consequences of endotracheal  intubation have been the subject of 
study by various authors over many years.
         Ried and Brace (1940) postulated that  the reflex circulatory responses to 
laryngeal  instrumentation  were  mediated  through  the  vagus  nerve  and  named  it  as 
“VASOVAGAL REFLEXES.” 
            King et al  (1951)23   observed that a marked though, transient rise in blood 
pressure is often encountered during laryngoscopy and manipulation of the epiglottis.
They also believed that the reflex mechanism to be non-specific. They stated that 
the impulses  initiating the  reflex are  probably  carried by  the vagus nerve while  the 
effector system is less clearly defined and may be due to decreased parasympathetic or 
increased sympathetic activity.
Prof.  ward  and king  (1960) in  their  study  documented  myocardial  ischemic 
changes due to reflex sympathoadrenal response following larygoscopy and intubation 
with mean increase in the systemic pressure of 40 mm of Hg even in normotensive 
individuals.
Tomori et al (1969)12 in their study observed that mechanical stimulation of four 
areas of the respiratory tract, the  nose, the epipharynx, the laryngopharynx and 
tracheobronchial tree  induced reflex cardiovascular responses associated with  enhanced 
neuronal activity in cervical sympathetic efferent fibres. It was more pronounced during 
stimulation of the epipharynx.
Corbett and kerr (1969)24 found a significant increase in mean arterial pressure and 
plasma nor-adrenaline levels one minute after intubation that gradually  regressed with 
time.  No significant  changes in  Adrenaline and Dopamine concentration were noted 
during the same period.
Forbes and Dally (1970)25 observed an increase in mean arterial  pressure  of 25 
mmHg in all 22 normotensive patients during laryngoscopy and endotracheal intubation. 
These response were interpreted as due to reflex sympathetic adrenal stimulation.
Prys-Roberts et al (1971)2 observed that increases in heart rate and blood pressure 
during  laryngoscopy  and  intubation were much more exaggerated in hypertensive 
patients than  in normotensives.
Victoria Faria  Baln and Normand A.G.(1974) in  the  article,  complications  of 
tracheal intubation have classified the neurogenic or reflex mediated complication into 
three different categories.
i. Laryngeal reflexes:  
Spasm of glottis,  bronchospasm,  apnoea, bradycardia, dysrhythmia    and  hypotension 
can  occur.
The   mere  presence  of  the  tracheal  tube  seem to  be  the  most  common  cause   of 
bronchospasm in   anaesthetized asthmatic patients.
ii. Laryngo-sympathetic  reflexes:   
 Tachydysrhythmia,  acute arterial hypertension and a hyperdynamic state  can  occur. 
It is related to an increased nor-adrenaline function of the total catecholomine. 
iii. Laryngospinal reflexes:  
coughing,  vomiting  and   bucking  may  occur
Stoelting  (1978)3 recommended  that  attempt  should  be  made  to  attenuate  the 
pressor response of laryngoscopy and tracheal intubation when the laryngoscopy time is 
likely to be more than 30 seconds.  when laryngoscopy is  prolonged laryngotracheal 
rather than intravenous lidocaine is necessary for attenuating the circulatory responses to 
intubation.
Stoelting et al (1979)6 studied the effect of sodium nitroprusside  
1 mcg/kg vs. 2 mcg/kg administered 15 seconds before performing laryngoscopy  and 
stated  that  2 microgram per  kilogram was  more  effective  in  attenuating  the  pressor 
response  associated  with  laryngoscopy  and  intubation.
Safawat et al (1981)8   studied the effect of propranolol  0.5 -1 mg administered 
intravenously  4 minutes before laryngoscopy in patients undergoing coronary artery 
bypass grafting.  They found that in patients treated with propranolol there was a marked 
cardiovascular stability after intubation.
Kautto et al (1982)4  observed that fentanyl in a low dose of 2 mcg / kg attenuated 
the pressor response to intubation.
Black  et  al  (1984)5   compared  the  efficacy  of  Alfentanil   with  fentanyl.  He 
observed  Alfentanil   to  be  effective  in  attenuating  the  hemodynamic  response  to 
larygoscopy and intubation and the effect appears to be of shorter duration than that of 
fentanyl. 
Ghignone  et  al  (1987)26 observed  that   clonidine  5  mcg/  kg  administered  to 
patients with hypertension (blood pressure from normal to moderate) was more effective 
in blunting the reflex tachycardia associatiated with largygoscopy and intubation than 
lidocaine –fentanyl   pretreatment.
Pouttu et al (1987)27 evaluated the effect of clonidine (4.5 mcg /kg) on stress 
response during  general anaesthesia in  21 female patients undergoing breast surgery 
they observed that clonidine attenuated the sympathoadrenal response and the increase 
in heart rate and arterial blood pressure were lower in that group.
Ghignone et  al  (1988)28 further  studied  the effect  of  clonidine  on intraocular 
pressure in elderly patients undergoing ophthalmic surgery. He observed that in patients 
on  clonidine who were managed with general anaesthesia,  rise in intraocular pressure 
was prevented and further the cardiovascular responses associated with largygoscopy 
and intubation were attenuated. They have recommended clonidine as a useful adjunct in 
the management of elderly patients coming for ophthalmic surgery.
Stone  et  al  (1988)29 in  a  non-double  blind  prospective  randomized  study, 
examined  the  electrocardiograms  of  128  mildly  hypertensive  patients  in  order  to 
determine the incidence of myocardial ischemia during anaesthesia. They observed the 
patients who were   not   on  chronic  antihypertensives   but   who   had   received   a 
small   dose   of   a   beta  blocker  (Atenolol.  Lebetolol  or  Oxprenolol)  along  with 
premedication  showed  significantly  reduced   incidence   (p<0.001)  of  myocardial 
ischemia.
Nishikawa et al (1991)10 studied about premedication with oral Clonidine in a 
dose of 5 mcg / kg and observed that it could attenuate the pressor response associated 
with larygoscopy and tracheal intubation.
Helfman et al (1991)30 compared Lidocaine, Fentanyl and Esmolol in attenuating 
the hemodynamic response to laryngoscopy and tracheal intubation.  Similar study was 
done by Feng et al (1996)31. In both the studies they have concluded that only Esmolol, 
a  cardioselective beta-blocker  offered a consistent and reliable protection in attenuating 
both tachycardia and hypertension associated with tracheal intubation.
Chadha et al (1992)32 evaluated oral clonidine pretreatment  for homodynamic 
stability  during  craniotomy.  They  observed  that  pressor  response  to  larygoscopy, 
tracheal  intubation and skin  infiltration was  significantly  attenuated  in  the  clonidine 
group. Further they have observed a reduction in sleep dose of   thiopentone sodium in 
clonidine pretreated patients.
  Dorman  et  al  (1993)33 observed  that  clonidine  (5  mcg  /kg  )  improves 
perioperative  myocardial  ischemia  in  patients  undergoing  Coronary  Artery  Bypass 
Surgery.   Yin et al (2002) observed the same results in coronary artery disease patients 
undergoing   non-cardiac surgery.
            Stuhmeier et al    (1996)34  studied  the   effect   of   small   dose  of  clonidine 
(2 mcg / kg ) in patients undergoing vascular surgery and observed that it reduces the 
incidence of myocardial ischemia.
            Thomson et al (1998)17  compared clonidine with conventional preanaesthetic 
medication (Morphine with  Scopolamine  or   Lorazepam )  in  patients  undergoing 
CABG and observed that clonidine produces sedation, relieves anxiety as effective as 
conventional premedicant. They also observed that  clonidine significantly reduced the 
isoflurane   requirements.
           Tetsu   kimura  et  al  (1998)35  observed  that   premedication with oral 
clonidine  (5 mcg/kg ) attenuated  the initial increase in heart rate without subsequent 
decrease in heart rate after intravenous Neostigmine – Atropine administration.  .
Grundmann  et  al  (1997)36 observed  the  intraoperative  administration  of  2 
mcg/kg of  clonidine  is  suitable  for  prevention  of   postanaesthetic  shivering  without 
prolonging the recovery time.
Michael A.Campagni et al (1999)37  evaluated oral clonidine and intravenous 
esmolol regarding  hemodynamic changes associated with injection of an epinephrine 
containing local anaesthetic solution during endoscopic sinus or septoplasty surgery in 
young healthy  non smokers. They observed that  Tablet clonidine  0.2-0.4 mg was 
efficient in blunting the hemodynamic response.
Handa et al (2000)21 conducted a randomized double blind, placebo controlled 
study to  determine  the  effect  of  oral  clonidine premedication  on the  side  effects  of 
intravenous  ketamine  anaestheia.  They  observed  that  oral  clonidine  5  mcg  /kg 
attenuated  the cardiostimulatory effects  and was associated with reduced  incidence 
and severity of nightmare and salivation attributable to intravenous ketamine.
Eva oddby – muhrbeck et al (2002)38 observed that co-induction with clonidine 
significantly increased the number of Postoperative nausea & vomiting (PONV) free 
patients after breast cancer surgery with General anaesthesia.
Dipak L.  Raval   et   al   (2002)22  conducted   a   study   to   compare   the 
effectiveness  of  oral  clonidine ( 4 microgram  per  kilogram) as  a  premedicant  and 
also  for  attenuation  of  hemodynamic  response  to  laryngoscopy  and  endotracheal 
intubation  with  oral  diazepam  and  placebo. Clonidine  provided  extra  advandage 
over   diazepam   and   placebo   by   blunting   hemodynamic   response   during 
laryngoscopy  and  endotracheal  intubation  and  also  by  its  antisialogogue  effect.
Javaid A.Zargar  et  al (2002)9  conducted  a  comparative  study  of  the  effect 
of  metoprolol  and  esmolol  on  rate pressure  product  and  ECG  changes  during 
laryngoscopy  and  endotracheal  intubation  in  controlled  hypertensive  patients.  They 
have  concluded  that  esmolol  in  a  bolus  dose  of  25 mg before  induction  of 
anaesthesia   was   comparatively   better   than   metoprolol   in   attenuating   the 
hemodynamic  responses  to   laryngoscopy  and  endotracheal  intubation  like  rate 
pressure  product  and  ECG  changes.         
                      DISCUSSION
Reflex  tachycardia  and  hypertension  during  laryngoscopy  and  tracheal  intubation 
occurs   frequently,  even  in  rightly  anaesthetized  normotensive  individuals39.  
Several  drugs  and  techniques  have  been  tried  in  an  attempt  to  obtund  the 
hyperactive  sympathoadrenal  pressor  response  to  laryngoscopy  and  intubation.  In 
our  study  we  have  compared  the  efficacy  of  oral  Clonidine ( 5 micrograms per 
kilogram)   and   oral   Atenolol  (50  milligram  single  dose)   in   attenuating   the 
hemodynamic  response  to  laryngoscopy  and  endotracheal  intubation.  75  patients 
were  studied  with  each  group  comprising  25  patients.
In  our  study, the  patients  in  the  Clonidine  group  were  better  sedated  (80% of 
patients with  sedation  score  2-3 )  when  compared  to  control  group (64% patients 
fully  awake) and  Atenolol  group ( 60% of  patients  fully  awake). Kumar et al40  and 
Ghignone  et al28  have also  reported    Clonidine  as a better  sedative  when  compared 
to  Diazepam  in  their  study.
In  our  study,  120  minutes  after  premedication , there  was  a  small  but  significant 
fall in  heart rate (from  81.84 ± 5.684  to 74.76±3.503  )  and  blood pressure  in  the 
clonidine  group. Kumar et al40 and                Ghignone et al28  also  observed  the  same 
with  oral Clonidine  premedication..
In   Atenolol   group,    120 minutes   after   premedication,   there   was   significant 
reduction  in  heart rate (from  80.8 ±  5.09 to  75.44 ±  4.273 ) but  the decrease  in  the 
blood pressure  was  not  significant.  Atenolol  probably  by  its  beta-1 adrenoreceptor 
blockade,  slows  the  conduction  of  cardiac  impulses  and  decreases  the  heart rate. 
The  blood  pressure  does  not  decrease  significantly  probably  because  Atenolol does 
not  lower  blood pressure  in  normotensive  individuals15 .
Laurito  et  al41  has  suggested  that  oral Clonidine, as  a premedicant  in  a  dosage  of 
5 micrograms  per  kilogram ( maximum 0.3 milligram)  
affords   hemodynamic   protection    to   patients   undergoing  a 
15 second laryngoscopy  but  not  for  patients  undergoing a  45 second  laryngoscopy. 
In  our  study,  we  have  used  the  same  dosage  of 
oral clonidine  and  we  have  limited  our  laryngoscopy  time  to  less than  15 seconds.
During laryngoscopy and  intubation,  the  heart rate  increased  in  all  the  groups  from 
their respective  preoperative  values ( increased  by  30% in  control  group , by  6% in 
Clonidine  group, by  10% in  the  Atenolol group). But,  the  increase  in  heart rate  in 
Clonidine  group  and  Atenolol  group  was  not  as  much  as  that  of  in   control 
group .
During laryngoscopy and intubation, the  blood pressure (systolic, diastolic and  mean 
arterial  pressure)  increased  in  all  the  three  groups               (mean  arterial  pressure 
increased  by  30.76% in  control  group, 11% in  Clonidine  group, 11.5%  in  Atenolol 
group). The  magnititude  of  increase  in  blood pressure  in  the  Clonidine  and 
Atenolol   groups  was  similar   and  the  increase  was  significantly   less   when 
compared  to  control  group. Nishikawa et al10, Pouttu  et  al27  and  Batra  et  al42 
obtained  similar  results when  using  oral Clonidine  as  a  premedicant. 
Clonidine   minimizes   the   increase   in   heart  rate   and   blood  pressure   during 
laryngoscopy  and  intubation  by  a complex  mechanism. Centrally, it  acts  on  the 
alpha-2 adrenoreceptors  and  causes decrease  in  central  sympathetic  tone  and  an 
increase   in   the   parasympathetic   tone.  Peripherally,  stimulation   of   alpha-2 
adrenoreceptors leads  to  diminished   release of   noradrenaline  from  the  nerve 
endings  to  the  vasculature  and  a reduction  in  peripheral  sympathetic  tone.  Beta 
adrenoreceptor   blockade  minimizes   increase   in   heart  rate   and   myocardial 
contractility  by  attenuating  the  positive  inotropic  and  chronotropic  effects  of 
increased  adrenergic  activity. Atenolol,  because  of  its  selective  beta  adrenergic 
antagonistic  activity  like  Metoprolol and Esmolol, is  used  to  prevent  the  reflex 
sympathoadrenal   discharge   mediated   tachycardia   and   hypertension   during 
procedures  of  laryngoscopy  and  endotracheal  intubation9. In  our  study,  in  the 
control  group, sinus  tachycardia  occurred   in  most  of  the  patients  whereas   no 
patients  in  the  Clonidine  group  and  Atenolol  group  had  any  arrhythmias.  In  all 
the  three  groups, no patient had  ECG  changes  suggestive  of  myocardial  ischemia. 
Oral  Clonidine premedication was associated  with  a  significant  decrease  in  the 
incidence of  postoperative  nausea  and  vomiting  in  our  study (12% in  Clonidine 
group vs.  40%  in  control group  and  36% in  Atenolol group). Antiemetic  property 
of   Clonidine  may   be   due   to   its   action   on   alpha-2  adrenoreceptors   located 
postsynaptically   in   the   area  postrema  and  reduction  in   the   emetic   impulses 
transmitted  to  the  vomiting  center  of  the  brainstem  reticular  formation43.  Eva 
Oddby-Muhrbeck  et  al38,  Carabine  et  al44 and  Joseph  park  et  al19 observed   the 
antiemetic  effect   of  Clonidine  in  their  studies.
During  the  24 hours  observation  period, there were  no  other  side effects  like 
ventilatory  depression, hypotension, hypertension, bradycardia or tachycardia  except 
for   the   sedation   in   the   Clonidine   group.  Clonidine   withdrawal   phenomena 
characterized  by  hypertension  and  tachycardia  did  not  develop  in  any  of  the 
patients  in  the  Clonidine  group.   Clonidine  withdrawal  phenomena  usually occurs 
after abrupt  cessation  of  chronic  treatment but  not  after  a  single  dose45.
                              CONCLUSION
Oral   Clonidine  and  oral   Atenolol   significantly   reduces  the  tachycardia   and 
hypertension  associated  with  laryngoscopy  and  endotracheal  intubation  Clonidine 
provides better sedation  and  decreases  the  incidence  of  postoperative  nausea  and 
vomiting.         
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